Teva Pharmaceutical ADR

Region Europa
ISIN US8816242098
Sektor Chemie & Pharma
Website http://www.tevapharm.com/

Teva Pharmaceuticals gehört zu den weltweit wichtigsten Pharmaunternehmen und gilt als größter Generika Hersteller.


News

Titel Datum
Teva receives FDA approval for Prolia biosimilar vor 9 Stunden
Teva gains approval of biosimilar of Amgen's Prolia vor einem Tag
Teva Gains on New Developments vor einem Tag
Teva Secures FDA Nod For PONLIMSI, Biosimilar Candidate To Xolair Applications Accepted By FDA & EMA
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Limited (TEVA), Monday announced that the...
vor einem Tag
Teva Pharmaceutical Industries Ltd: Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI (denosumab-adet) and Dual Filing Ac...
Teva's biosimilar, PONLIMSI, is now FDA-approved across all indications of the reference product,...
vor einem Tag